These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

423 related items for PubMed ID: 12186951

  • 1. Normal timing of oligodendrocyte development from genetically engineered, lineage-selectable mouse ES cells.
    Billon N, Jolicoeur C, Ying QL, Smith A, Raff M.
    J Cell Sci; 2002 Sep 15; 115(Pt 18):3657-65. PubMed ID: 12186951
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Enrichment of Oligodendrocyte Progenitors from Differentiated Neural Precursors by Clonal Sphere Preparations.
    Umebayashi D, Coles B, van der Kooy D.
    Stem Cells Dev; 2016 May 01; 25(9):712-28. PubMed ID: 26972950
    [Abstract] [Full Text] [Related]

  • 4. Extracellular and intracellular regulation of oligodendrocyte development: roles of Sonic hedgehog and expression of E proteins.
    Sussman CR, Davies JE, Miller RH.
    Glia; 2002 Oct 01; 40(1):55-64. PubMed ID: 12237843
    [Abstract] [Full Text] [Related]

  • 5. Differentiation of oligodendrocyte progenitor cells from dissociated monolayer and feeder-free cultured pluripotent stem cells.
    Yamashita T, Miyamoto Y, Bando Y, Ono T, Kobayashi S, Doi A, Araki T, Kato Y, Shirakawa T, Suzuki Y, Yamauchi J, Yoshida S, Sato N.
    PLoS One; 2017 Oct 01; 12(2):e0171947. PubMed ID: 28192470
    [Abstract] [Full Text] [Related]

  • 6. The extracellular matrix glycoprotein Tenascin-C is expressed by oligodendrocyte precursor cells and required for the regulation of maturation rate, survival and responsiveness to platelet-derived growth factor.
    Garwood J, Garcion E, Dobbertin A, Heck N, Calco V, ffrench-Constant C, Faissner A.
    Eur J Neurosci; 2004 Nov 01; 20(10):2524-40. PubMed ID: 15548197
    [Abstract] [Full Text] [Related]

  • 7. A non-transformed oligodendrocyte precursor cell line, OL-1, facilitates studies of insulin-like growth factor-I signaling during oligodendrocyte development.
    Lagarde WH, Benjamin R, Heerens AT, Ye P, Cohen RI, Moats-Staats BM, D'Ercole AJ.
    Int J Dev Neurosci; 2007 Apr 01; 25(2):95-105. PubMed ID: 17306496
    [Abstract] [Full Text] [Related]

  • 8. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation.
    Liu S, Qu Y, Stewart TJ, Howard MJ, Chakrabortty S, Holekamp TF, McDonald JW.
    Proc Natl Acad Sci U S A; 2000 May 23; 97(11):6126-31. PubMed ID: 10823956
    [Abstract] [Full Text] [Related]

  • 9. Evidence that perinatal and adult NG2-glia are not conventional oligodendrocyte progenitors and do not depend on axons for their survival.
    Greenwood K, Butt AM.
    Mol Cell Neurosci; 2003 Aug 23; 23(4):544-58. PubMed ID: 12932436
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The tetraspanin protein, CD9, is expressed by progenitor cells committed to oligodendrogenesis and is linked to beta1 integrin, CD81, and Tspan-2.
    Terada N, Baracskay K, Kinter M, Melrose S, Brophy PJ, Boucheix C, Bjartmar C, Kidd G, Trapp BD.
    Glia; 2002 Dec 23; 40(3):350-9. PubMed ID: 12420314
    [Abstract] [Full Text] [Related]

  • 12. Differentiation of human oligodendrocytes from pluripotent stem cells.
    Hu BY, Du ZW, Zhang SC.
    Nat Protoc; 2009 Dec 23; 4(11):1614-22. PubMed ID: 19834476
    [Abstract] [Full Text] [Related]

  • 13. Involvement of CD45 in central nervous system myelination.
    Nakahara J, Seiwa C, Tan-Takeuchi K, Gotoh M, Kishihara K, Ogawa M, Asou H, Aiso S.
    Neurosci Lett; 2005 May 06; 379(2):116-21. PubMed ID: 15823427
    [Abstract] [Full Text] [Related]

  • 14. Human fetal oligodendrocyte progenitor cells from different gestational stages exhibit substantially different potential to myelinate.
    Cui QL, D'Abate L, Fang J, Leong SY, Ludwin S, Kennedy TE, Antel J, Almazan G.
    Stem Cells Dev; 2012 Jul 20; 21(11):1831-7. PubMed ID: 22122665
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Oligodendrocyte and astrocyte development in rodents: an in situ and immunohistological analysis during embryonic development.
    Liu Y, Wu Y, Lee JC, Xue H, Pevny LH, Kaprielian Z, Rao MS.
    Glia; 2002 Oct 20; 40(1):25-43. PubMed ID: 12237841
    [Abstract] [Full Text] [Related]

  • 17. Oligodendrocyte maturation is inhibited by bone morphogenetic protein.
    See J, Zhang X, Eraydin N, Mun SB, Mamontov P, Golden JA, Grinspan JB.
    Mol Cell Neurosci; 2004 Aug 20; 26(4):481-92. PubMed ID: 15276151
    [Abstract] [Full Text] [Related]

  • 18. Genetic evidence that Nkx2.2 and Pdgfra are major determinants of the timing of oligodendrocyte differentiation in the developing CNS.
    Zhu Q, Zhao X, Zheng K, Li H, Huang H, Zhang Z, Mastracci T, Wegner M, Chen Y, Sussel L, Qiu M.
    Development; 2014 Feb 20; 141(3):548-55. PubMed ID: 24449836
    [Abstract] [Full Text] [Related]

  • 19. Oligodendroglial expression of TrkB independently regulates myelination and progenitor cell proliferation.
    Wong AW, Xiao J, Kemper D, Kilpatrick TJ, Murray SS.
    J Neurosci; 2013 Mar 13; 33(11):4947-57. PubMed ID: 23486965
    [Abstract] [Full Text] [Related]

  • 20. Syndecan-3 and perlecan are differentially expressed by progenitors and mature oligodendrocytes and accumulate in the extracellular matrix.
    Winkler S, Stahl RC, Carey DJ, Bansal R.
    J Neurosci Res; 2002 Aug 15; 69(4):477-87. PubMed ID: 12210841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.